Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Dexamethasone sodium phosphate - Generic Drug Details

« Back to Dashboard
Dexamethasone sodium phosphate is the generic ingredient in thirteen branded drugs marketed by Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Ucb Inc, Fresenius Kabi Usa, Intl Medication, Teva Parenteral, Pharmafair, Luitpold, Wyeth Ayerst, Cent Pharms, Alcon, Abraxis Pharm, Bel Mar, Akorn, Dell Labs, Lyphomed, Bausch And Lomb, Sola Barnes Hind, Merck, Alcon Pharms Ltd, Aurobindo Pharma Ltd, and Organon Usa Inc, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for dexamethasone sodium phosphate. Twenty-four suppliers are listed for this compound.

Summary for Generic Name: dexamethasone sodium phosphate

Drug Master File Entries: see list38
Suppliers / Packagers: see list24
Bulk Api Vendors: see list71
Clinical Trials: see list2,067
Patent Applications: see list3,168
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dexamethasone sodium phosphate at DailyMed

Pharmacology for Ingredient: dexamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd
dexamethasone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC, OTIC088771-001Jan 16, 1985RXNoYes► subscribe► subscribe
Organon Usa Inc
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-002Approved Prior to Jan 1, 1982DISCNYesNo► subscribe► subscribe
Mylan Labs Ltd
dexamethasone sodium phosphate
INJECTABLE;INJECTION040803-001Aug 29, 2008RXNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.